Reid Huber invests as a partner at Third Rock Ventures and serves on the boards of biotechnology companies including Asher Bio, insitro and MOMA Therapeutics. Previously served as executive vice president and chief scientific officer at Incyte after working at DuPont, Bristol Myers Squibb and the National Institutes of Health.

Unclaimed profile

Reid Huber invests as a partner at Third Rock Ventures and serves on the boards of biotechnology companies including Asher Bio, insitro and MOMA Therapeutics. Previously served as executive vice president and chief scientific officer at Incyte after working at DuPont, Bristol Myers Squibb and the National Institutes of Health.

Career

Reid Huber holds a BS, Molecular Genetics and Biochemistry from Murray State University and a PhD, Human and Molecular Genetics from Washington University in St. Louis.

Partner at Third Rock Ventures until Present
Board Member at Asher Bio until Present
Board Member at insitro until Present
Board Member at Merida Biosciences until Present
Board Member at MOMA Therapeutics until Present
Board Member at Rapport Therapeutics until Present
Board Member at Synnovation Therapeutics until Present
Board Member at Terremoto Biosciences until Present
Board Member at Syremis Therapeutics until Present

Reid's Collections

Reid's Lists

In these lists

Cosigns Given